OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
JMAS$238.0057

Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT

Life & Health InsuranceVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. Its liquidity position is marked by a low liquidity risk, with cash and equivalents amounting to 8,752,375,460 IDR. The price-to-book ratio of 1.94 suggests that the market values the company at a premium to its book value. The company's return on equity of 2.31% and return on assets of 0.92% indicate relatively modest profitability compared to industry benchmarks. Profitability metrics show a net income of 2,828,925,060 IDR, despite an operating loss of -792,093,870 IDR. The company's return on equity of 2.31% is below the typical performance of industry peers, suggesting that it is not generating strong returns for shareholders. The operating cash flow of -9,060,379,270 IDR indicates a negative cash flow from operations, which may be a concern for long-term sustainability. The company's revenue is derived from a mix of group and individual insurance products, with no specific revenue concentration disclosed in the input data. The geographic exposure is primarily within Indonesia, as the company is based there and operates in the local market. The input data does not provide a breakdown of revenue by region or segment. The company's growth trajectory is not clearly defined in the input data, as there are no specific revenue growth projections or historical growth rates provided. The free cash flow of 3,553,696,200 IDR suggests that the company is generating positive cash flow after capital expenditures, which could support future growth initiatives. However, the operating loss and negative operating cash flow may limit the company's ability to invest in growth. The risk assessment indicates a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is free of long-term debt, which reduces financial risk. The absence of dilution risk suggests that the company is not expected to issue additional shares in the near term, which is favorable for existing shareholders. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's financial snapshot does not include any recent events or transcripts that would provide additional insight into its performance or strategic direction. The input data does not provide information on recent regulatory changes or market developments that could impact the company.

30-day price · JMAS+68.00 (+33.3%)
Low$193.00High$290.00Close$272.00As of17 May, 00:00 UTC
Profile
CompanyAsuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT
TickerJMAS.JK
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk is an Indonesia-based sharia life insurance company that provides group and individual insurance products, including JMA Salama Micro Insurance and JMA Asyifa Insurance.

Classification. The company is classified under the Financials economic sector, Insurance business sector, and Life & Health Insurance industry with a confidence level of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. Its liquidity position is marked by a low liquidity risk, with cash and equivalents amounting to 8,752,375,460 IDR. The price-to-book ratio of 1.94 suggests that the market values the company at a premium to its book value. The company's return on equity of 2.31% and return on assets of 0.92% indicate relatively modest profitability compared to industry benchmarks. Profitability metrics show a net income of 2,828,925,060 IDR, despite an operating loss of -792,093,870 IDR. The company's return on equity of 2.31% is below the typical performance of industry peers, suggesting that it is not generating strong returns for shareholders. The operating cash flow of -9,060,379,270 IDR indicates a negative cash flow from operations, which may be a concern for long-term sustainability. The company's revenue is derived from a mix of group and individual insurance products, with no specific revenue concentration disclosed in the input data. The geographic exposure is primarily within Indonesia, as the company is based there and operates in the local market. The input data does not provide a breakdown of revenue by region or segment. The company's growth trajectory is not clearly defined in the input data, as there are no specific revenue growth projections or historical growth rates provided. The free cash flow of 3,553,696,200 IDR suggests that the company is generating positive cash flow after capital expenditures, which could support future growth initiatives. However, the operating loss and negative operating cash flow may limit the company's ability to invest in growth. The risk assessment indicates a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is free of long-term debt, which reduces financial risk. The absence of dilution risk suggests that the company is not expected to issue additional shares in the near term, which is favorable for existing shareholders. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's financial snapshot does not include any recent events or transcripts that would provide additional insight into its performance or strategic direction. The input data does not provide information on recent regulatory changes or market developments that could impact the company.
Key takeaways
  • The company has a strong liquidity position with significant cash and equivalents.
  • The company's profitability is modest, with a return on equity of 2.31%.
  • The company's capital structure is free of long-term debt, reducing financial risk.
  • The company's growth trajectory is not clearly defined in the input data.
  • The company's risk assessment indicates low liquidity and dilution risks.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue
Gross profit
Operating income-$792.1M
Net income$2.83B
R&D
SG&A
D&A
SBC
Operating cash flow-$9.06B
CapEx-$599.4M
Free cash flow$3.55B
Total assets$306.18B
Total liabilities$183.68B
Total equity$122.50B
Cash & equivalents$8.75B
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$238.00
Market cap$238.00B
Enterprise value$229.25B
P/E84.1
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B1.9
P/Tangible book1.9
Tangible book$122.50B
Net cash$8.75B
Current ratio
Debt/Equity0.0
ROA0.9%
ROE2.3%
Cash conversion-3.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricJMASActivity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity0.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:46 UTC#c1f13ef8
Market quoteclose IDR 238.00 · shares 1.00B diluted
no public URL
2026-05-04 18:46 UTC#6b554183
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:47 UTCJob: 0da13b2a